From the Pediatric Emergency, Hamad General Hospital, Hamad Medical Corporation (HMC) and College of Medicine, Qatar University, Doha, Qatar.
Paediatric Emergency, Hamad General Hospital, Hamad Medical Corporation (HMC), Doha, Qatar.
Pediatr Emerg Care. 2024 Mar 1;40(3):180-186. doi: 10.1097/PEC.0000000000002965. Epub 2023 May 11.
Several pain management tools exist but with limitations in their efficacy or applicability. The EMLA (eutectic mixture of local anesthetics) cream is currently used for pain relief for needle-related procedures; however, it needs a minimum of 30 to 45 minutes to be effective. The Buzzy is a device that generates vibrations with cold leading to quicker pain relief. Our aim was to evaluate the effect of the Buzzy device in pain and anxiety reduction compared with EMLA cream in children requiring intravenous cannulation or venepuncture.
This was a randomized clinical trial comparing pain and anxiety reduction by Buzzy device with the standard care (EMLA cream) in children aged 2 to 14 years who required blood extraction or intravenous cannulation based on their clinical needs. Eligible patients were randomized to either Buzzy device as the intervention or EMLA cream as the control. The outcome measures were the degree of pain scores and anxiety ratings at different stages of the needle-related procedures.
A total of 300 patients with a mean age of 6.5 ± 3.1 years were enrolled. Baseline characteristics were similar between the Buzzy device and EMLA cream groups. The observed pain scores by research nurses and a parent were significantly lower in the EMLA group compared with the Buzzy device group; however, the pain scores by the self-assessment scale were not statistically significant with mean difference of -0.332, 95% confidence interval, -0.635 to -0.028 ( P = 0.062). The level of anxiety was significantly lower in EMLA compared with Buzzy device ( P = 0. 0.0001). Both staff and parents' satisfaction, success rate of cannulation, type of blood tests, and comment on the physician on the results were similar in both groups.
Pain and anxiety relief using the Buzzy device is not as effective as EMLA cream in children requiring venepuncture. However, rapid onset of action of the Buzzy device is valuable in decreasing waiting time in a busy emergency department.
clinicaltrials.gov Identifier: NCT05354739.
有几种疼痛管理工具,但在疗效或适用性方面存在局限性。目前,EMLA(局部麻醉剂的共晶混合物)乳膏用于缓解与针相关的操作引起的疼痛;然而,它需要至少 30 到 45 分钟才能起效。Buzzy 是一种产生振动和冷感的设备,可更快地缓解疼痛。我们的目的是评估与 EMLA 乳膏相比,Buzzy 设备在需要静脉穿刺或采血的儿童中减轻疼痛和焦虑的效果。
这是一项随机临床试验,比较了 Buzzy 设备与标准护理(EMLA 乳膏)在因临床需要需要采血或静脉穿刺的 2 至 14 岁儿童中减轻疼痛和焦虑的效果。符合条件的患者被随机分配到 Buzzy 设备干预组或 EMLA 乳膏对照组。结果测量是在与针相关的操作的不同阶段的疼痛评分和焦虑程度。
共纳入 300 名平均年龄为 6.5±3.1 岁的患者。Buzzy 设备组和 EMLA 乳膏组的基线特征相似。研究护士和家长观察到的疼痛评分在 EMLA 组明显低于 Buzzy 设备组;然而,自我评估量表的疼痛评分无统计学意义,平均差值为-0.332,95%置信区间为-0.635 至-0.028(P=0.062)。与 Buzzy 设备相比,EMLA 组的焦虑水平明显更低(P=0.0001)。两组人员对置管成功率、采血类型和对医生结果的评价满意度、家长满意度均相似。
与 EMLA 乳膏相比,Buzzy 设备在需要静脉穿刺的儿童中缓解疼痛和焦虑的效果并不理想。然而,Buzzy 设备的快速起效在繁忙的急诊科减少等待时间方面具有价值。
clinicaltrials.gov 标识符:NCT05354739。